CN111978314A - A kind of preparation method of secondary amine compound containing thiazole ring - Google Patents
A kind of preparation method of secondary amine compound containing thiazole ring Download PDFInfo
- Publication number
- CN111978314A CN111978314A CN202010878159.9A CN202010878159A CN111978314A CN 111978314 A CN111978314 A CN 111978314A CN 202010878159 A CN202010878159 A CN 202010878159A CN 111978314 A CN111978314 A CN 111978314A
- Authority
- CN
- China
- Prior art keywords
- chlorothiazole
- preparation
- secondary amine
- amine compound
- thiazole ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 secondary amine compound Chemical class 0.000 title claims abstract description 86
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 33
- 238000006243 chemical reaction Methods 0.000 claims abstract description 62
- 229910000033 sodium borohydride Inorganic materials 0.000 claims abstract description 21
- 239000012279 sodium borohydride Substances 0.000 claims abstract description 21
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims abstract description 20
- 229940040526 anhydrous sodium acetate Drugs 0.000 claims abstract description 20
- 239000003960 organic solvent Substances 0.000 claims abstract description 10
- 239000002253 acid Substances 0.000 claims abstract description 5
- WDWDWGRYHDPSDS-UHFFFAOYSA-N methanimine Chemical class N=C WDWDWGRYHDPSDS-UHFFFAOYSA-N 0.000 claims abstract description 4
- 238000005984 hydrogenation reaction Methods 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 72
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 46
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 39
- 229960000583 acetic acid Drugs 0.000 claims description 21
- PKCBQQXHFIDIIG-UHFFFAOYSA-N 2-chloro-1,3-thiazole-5-carbaldehyde Chemical compound ClC1=NC=C(C=O)S1 PKCBQQXHFIDIIG-UHFFFAOYSA-N 0.000 claims description 19
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 17
- 239000012362 glacial acetic acid Substances 0.000 claims description 17
- 239000012074 organic phase Substances 0.000 claims description 17
- 239000002904 solvent Substances 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 10
- 150000003141 primary amines Chemical class 0.000 claims description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- 150000001412 amines Chemical class 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 3
- 230000035484 reaction time Effects 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- KCDQBIMJBRASQE-UHFFFAOYSA-N (2-chloro-1,3-thiazol-5-yl)methanamine Chemical class NCC1=CN=C(Cl)S1 KCDQBIMJBRASQE-UHFFFAOYSA-N 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 239000003054 catalyst Substances 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- 239000012046 mixed solvent Substances 0.000 claims description 2
- 238000012805 post-processing Methods 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 238000006722 reduction reaction Methods 0.000 claims description 2
- 238000002390 rotary evaporation Methods 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- GKKVXHWSMPCNOU-UHFFFAOYSA-N 2-chloro-n-methyl-1,3-thiazol-5-amine Chemical class CNC1=CN=C(Cl)S1 GKKVXHWSMPCNOU-UHFFFAOYSA-N 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 230000007613 environmental effect Effects 0.000 abstract 1
- 125000002924 primary amino group Chemical class [H]N([H])* 0.000 abstract 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 30
- 239000007789 gas Substances 0.000 description 15
- 239000003208 petroleum Substances 0.000 description 15
- 238000001556 precipitation Methods 0.000 description 15
- 239000012043 crude product Substances 0.000 description 9
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 6
- RZXMPPFPUUCRFN-UHFFFAOYSA-N p-toluidine Chemical compound CC1=CC=C(N)C=C1 RZXMPPFPUUCRFN-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 125000004494 ethyl ester group Chemical group 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000002917 insecticide Substances 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 239000000575 pesticide Substances 0.000 description 4
- KLEYVGWAORGTIT-UHFFFAOYSA-N 2-chlorothiazole Chemical compound ClC1=NC=CS1 KLEYVGWAORGTIT-UHFFFAOYSA-N 0.000 description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 150000003557 thiazoles Chemical class 0.000 description 3
- DOLQYFPDPKPQSS-UHFFFAOYSA-N 3,4-dimethylaniline Chemical compound CC1=CC=C(N)C=C1C DOLQYFPDPKPQSS-UHFFFAOYSA-N 0.000 description 2
- HRXZRAXKKNUKRF-UHFFFAOYSA-N 4-ethylaniline Chemical compound CCC1=CC=C(N)C=C1 HRXZRAXKKNUKRF-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000005941 Thiamethoxam Substances 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- VULHYRAYXYTONQ-UHFFFAOYSA-N n-phenylmethanimine Chemical compound C=NC1=CC=CC=C1 VULHYRAYXYTONQ-UHFFFAOYSA-N 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- NWWZPOKUUAIXIW-FLIBITNWSA-N thiamethoxam Chemical compound [O-][N+](=O)\N=C/1N(C)COCN\1CC1=CN=C(Cl)S1 NWWZPOKUUAIXIW-FLIBITNWSA-N 0.000 description 2
- NAZDVUBIEPVUKE-UHFFFAOYSA-N 2,5-dimethoxyaniline Chemical compound COC1=CC=C(OC)C(N)=C1 NAZDVUBIEPVUKE-UHFFFAOYSA-N 0.000 description 1
- FOYHNROGBXVLLX-UHFFFAOYSA-N 2,6-diethylaniline Chemical compound CCC1=CC=CC(CC)=C1N FOYHNROGBXVLLX-UHFFFAOYSA-N 0.000 description 1
- ZFCOUBUSGHLCDT-UHFFFAOYSA-N 2-(trifluoromethoxy)aniline Chemical compound NC1=CC=CC=C1OC(F)(F)F ZFCOUBUSGHLCDT-UHFFFAOYSA-N 0.000 description 1
- VBLXCTYLWZJBKA-UHFFFAOYSA-N 2-(trifluoromethyl)aniline Chemical compound NC1=CC=CC=C1C(F)(F)F VBLXCTYLWZJBKA-UHFFFAOYSA-N 0.000 description 1
- AXNUZKSSQHTNPZ-UHFFFAOYSA-N 3,4-difluoroaniline Chemical compound NC1=CC=C(F)C(F)=C1 AXNUZKSSQHTNPZ-UHFFFAOYSA-N 0.000 description 1
- PNPCRKVUWYDDST-UHFFFAOYSA-N 3-chloroaniline Chemical compound NC1=CC=CC(Cl)=C1 PNPCRKVUWYDDST-UHFFFAOYSA-N 0.000 description 1
- QZVQQUVWFIZUBQ-UHFFFAOYSA-N 3-fluoroaniline Chemical compound NC1=CC=CC(F)=C1 QZVQQUVWFIZUBQ-UHFFFAOYSA-N 0.000 description 1
- RGDQRXPEZUNWHX-UHFFFAOYSA-N 3-methylpyridin-2-amine Chemical compound CC1=CC=CN=C1N RGDQRXPEZUNWHX-UHFFFAOYSA-N 0.000 description 1
- XCCNRBCNYGWTQX-UHFFFAOYSA-N 3-propan-2-ylaniline Chemical compound CC(C)C1=CC=CC(N)=C1 XCCNRBCNYGWTQX-UHFFFAOYSA-N 0.000 description 1
- QSNSCYSYFYORTR-UHFFFAOYSA-N 4-chloroaniline Chemical compound NC1=CC=C(Cl)C=C1 QSNSCYSYFYORTR-UHFFFAOYSA-N 0.000 description 1
- LHZOTJOOBRODLL-UHFFFAOYSA-N 4-oxo-1-(pyrimidin-5-ylmethyl)-3-[3-(trifluoromethyl)phenyl]pyrido[1,2-a]pyrimidin-5-ium-2-olate Chemical compound O=C1[N+]2=CC=CC=C2N(CC=2C=NC=NC=2)C([O-])=C1C1=CC=CC(C(F)(F)F)=C1 LHZOTJOOBRODLL-UHFFFAOYSA-N 0.000 description 1
- ODGIMMLDVSWADK-UHFFFAOYSA-N 4-trifluoromethylaniline Chemical compound NC1=CC=C(C(F)(F)F)C=C1 ODGIMMLDVSWADK-UHFFFAOYSA-N 0.000 description 1
- ZBNZXTGUTAYRHI-UHFFFAOYSA-N Dasatinib Chemical compound C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1Cl ZBNZXTGUTAYRHI-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WHWHBAUZDPEHEM-UHFFFAOYSA-N Fenthiaprop Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OC1=NC2=CC=C(Cl)C=C2S1 WHWHBAUZDPEHEM-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000002067 L01XE06 - Dasatinib Substances 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- OKBVVJOGVLARMR-QSWIMTSFSA-N cefixime Chemical compound S1C(N)=NC(C(=N\OCC(O)=O)\C(=O)N[C@@H]2C(N3C(=C(C=C)CS[C@@H]32)C(O)=O)=O)=C1 OKBVVJOGVLARMR-QSWIMTSFSA-N 0.000 description 1
- 229960002129 cefixime Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229960002448 dasatinib Drugs 0.000 description 1
- PVDQXPBKBSCNJZ-UHFFFAOYSA-N dicloromezotiaz Chemical compound CC1=CC=C[N+](C(C(C=2C=C(Cl)C=C(Cl)C=2)=C2[O-])=O)=C1N2CC1=CN=C(Cl)S1 PVDQXPBKBSCNJZ-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 238000006197 hydroboration reaction Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- XIGAUIHYSDTJHW-UHFFFAOYSA-N mefenacet Chemical compound N=1C2=CC=CC=C2SC=1OCC(=O)N(C)C1=CC=CC=C1 XIGAUIHYSDTJHW-UHFFFAOYSA-N 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N mono-methylamine Natural products NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- VMPITZXILSNTON-UHFFFAOYSA-N o-anisidine Chemical compound COC1=CC=CC=C1N VMPITZXILSNTON-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 238000006268 reductive amination reaction Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000004308 thiabendazole Substances 0.000 description 1
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 1
- 229960004546 thiabendazole Drugs 0.000 description 1
- 235000010296 thiabendazole Nutrition 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及一种含噻唑环的仲胺类化合物的制备方法。它由伯胺与2‑氯‑5‑噻唑醛、无水乙酸钠溶解在有机溶剂中,弱酸环境下微波合成制得(E)‑N‑(2‑氯噻唑‑5‑yl)亚甲基胺衍生物,(E)‑N‑(2‑氯噻唑‑5‑yl)亚甲基胺衍生物与硼氢化钠在有机溶剂中加氢还原制得N‑(2‑氯噻唑‑5‑yl)甲基胺衍生物。其制备方法简单、操作方便、反应快速,符合绿色环保要求,提高了经济效益。The invention relates to a preparation method of a secondary amine compound containing a thiazole ring. It is prepared by dissolving primary amine, 2-chloro-5-thiazole aldehyde and anhydrous sodium acetate in an organic solvent, and microwave synthesis in a weak acid environment to prepare (E)-N-(2-chlorothiazole-5-yl)methylene Amine derivatives, (E)-N-(2-chlorothiazole-5-yl) methyleneamine derivatives and sodium borohydride in organic solvent hydrogenation reduction to obtain N-(2-chlorothiazole-5-yl ) methylamine derivatives. The preparation method is simple, the operation is convenient, the reaction is fast, the green environmental protection requirements are met, and the economic benefit is improved.
Description
技术领域technical field
本发明涉及一种含噻唑环的仲胺类化合物的制备方法。The invention relates to a preparation method of a secondary amine compound containing a thiazole ring.
背景技术Background technique
噻唑环是一类含氮、硫杂原子的五元芳香杂环,具有丰富的电子,易形成氢键、与金属离子配位以及堆积、静电和疏水作用等多种非共价键相互作用。噻唑类化合物广泛应用于医药、农药、材料、生物染色剂等领域。噻唑类化合物可与生物体内多种酶和受体等靶点结合从而表现出多种生物活性,已经有众多噻唑类化合物用于临床,如抗生素药物头孢克肟(Cefixime)、抗癌药物达沙替尼(Dasatinib)等均为临床首选的一线药物。噻唑类农药研发异常活跃,具有优良的除草、植物生长调控、杀菌、杀虫效果,已有大量噻唑类农药如噻菌灵(Thiabendazole)、噻虫嗪(Thiamethoxam)、噻唑禾草灵(Fenthiaprop)等用于农业生产。胺类化合物是重要的有机合成中间体,可用于医用药物的制备,也可用于合成各种杀虫剂、杀菌剂、除草剂,如苯噻草胺(Mefenacet)、噻虫嗪(Thiamethoxam)等。通过合成一系列含噻唑环的仲胺类化合物将两者优势结合,以得到高效、低毒的生物活性用于农药研发。如美国杜邦公司的介离子类杀虫剂含嘧啶环triflumezopyrim和含噻唑环的dicloromezotiaz具有优良的活性、独特的结构、不寻常的生理作用,提供了新的防治害虫措施。Thiazole ring is a kind of five-membered aromatic heterocyclic ring containing nitrogen and sulfur heteroatoms, which is rich in electrons, easy to form hydrogen bonds, coordinate with metal ions, and interact with various non-covalent bonds such as stacking, electrostatic and hydrophobic interactions. Thiazole compounds are widely used in medicine, pesticides, materials, biological dyes and other fields. Thiazoles can bind to a variety of enzymes and receptors in vivo and exhibit a variety of biological activities. Many thiazoles have been used in clinical practice, such as the antibiotic drug Cefixime, the anticancer drug Dasa Dasatinib and other drugs are the first-line drugs of choice in clinical practice. The research and development of thiazole pesticides is very active, with excellent herbicidal, plant growth regulation, bactericidal, and insecticidal effects. There are a large number of thiazole pesticides such as Thiabendazole, Thiamethoxam, and Fenthiaprop. etc. for agricultural production. Amine compounds are important organic synthesis intermediates, which can be used in the preparation of medical drugs, as well as in the synthesis of various insecticides, fungicides, herbicides, such as Mefenacet, Thiamethoxam, etc. . By synthesizing a series of secondary amine compounds containing thiazole ring, the advantages of the two are combined to obtain high-efficiency and low-toxicity biological activity for pesticide research and development. For example, the mesoionic insecticides of DuPont Company in the United States have pyrimidine ring-containing triflumezopyrim and thiazole ring-containing dicloromezotiaz, which have excellent activity, unique structure, and unusual physiological effects, providing new pest control measures.
发明内容SUMMARY OF THE INVENTION
针对现有技术中存在的上述问题,本发明的目的在于提供含噻唑环的仲胺类化合物的制备方法;本发明基于伯胺RNH2、2-氯-5-噻唑醛的结构,通过还原胺化的方式,先将醛、胺微波合成一系列仲胺化合物,然后用硼氢化钠将其还原为一系列仲胺化合物,最终设计合成了一系列N-(2-氯噻唑-5-yl)甲基胺化合物。In view of the above problems existing in the prior art, the purpose of the present invention is to provide a preparation method of a secondary amine compound containing a thiazole ring; the present invention is based on the structure of primary amine RNH 2 and 2-chloro-5-thiazole aldehyde, by reducing the amine A series of secondary amine compounds were first synthesized from aldehydes and amines by microwave, and then reduced to a series of secondary amine compounds with sodium borohydride, and finally a series of N-(2-chlorothiazole-5-yl) was designed and synthesized. methylamine compound.
所述的一种含噻唑环的仲胺类化合物的制备方法,所述含噻唑环的仲胺类化合物的结构式如式(Ⅰ)所示,其特征在于所述制备方法包括如下步骤:Described a kind of preparation method of secondary amine compound containing thiazole ring, the structural formula of described secondary amine compound containing thiazole ring is shown in formula (I), it is characterized in that described preparation method comprises the following steps:
1)将伯胺、2-氯-5-噻唑醛及无水乙酸钠溶解在有机溶剂A中,加入酸作为催化剂,置于微波反应釜中反应制得如式(Ⅱ)所示(E)-N-(2-氯噻唑-5-yl)亚甲基胺衍生物;1) Dissolve primary amine, 2-chloro-5-thiazolaldehyde and anhydrous sodium acetate in organic solvent A, add acid as a catalyst, and place in a microwave reactor to react to obtain (E) shown in formula (II) -N-(2-chlorothiazole-5-yl)methyleneamine derivatives;
2)将步骤1)得到的式(Ⅱ)所示的(E)-N-(2-氯噻唑-5-yl)亚甲基胺衍生物与硼氢化钠在有机溶剂B中,在室温下进行加氢还原反应,后处理制得如式(Ⅰ)所示的N-(2-氯噻唑-5-yl)甲基胺衍生物,2) The (E)-N-(2-chlorothiazole-5-yl)methyleneamine derivative represented by the formula (II) obtained in step 1) is mixed with sodium borohydride in organic solvent B at room temperature Carry out hydrogenation reduction reaction, post-treatment to obtain N-(2-chlorothiazole-5-yl)methylamine derivative represented by formula (I),
伯胺RNH2、式(Ⅰ)和式(Ⅱ)中:R为烷基、烷氧基、芳香基、杂环基,伯胺中的取代基与R相同。In primary amine RNH 2 , formula (I) and formula (II): R is an alkyl group, an alkoxy group, an aryl group, a heterocyclic group, and the substituents in the primary amine are the same as R.
所述的一种含噻唑环的仲胺类化合物的制备方法,其特征在于步骤1)中的2-氯-5-噻唑醛与伯胺的物质的量比为1:0.7-1.4;2-氯-5-噻唑醛与无水乙酸钠的物质的量之比为1:2-3。The method for preparing a thiazole ring-containing secondary amine compound is characterized in that the material ratio of 2-chloro-5-thiazole aldehyde to primary amine in step 1) is 1:0.7-1.4; 2- The mass ratio of chloro-5-thiazolaldehyde to anhydrous sodium acetate was 1:2-3.
所述的一种含噻唑环的仲胺类化合物的制备方法,其特征在于步骤1)中的酸为冰醋酸或盐酸。The method for preparing a thiazole ring-containing secondary amine compound is characterized in that the acid in step 1) is glacial acetic acid or hydrochloric acid.
所述的一种含噻唑环的仲胺类化合物的制备方法,其特征在于步骤1)中的有机溶剂A为乙醇、甲苯或二甲基甲酰胺。The method for preparing a thiazole ring-containing secondary amine compound is characterized in that the organic solvent A in step 1) is ethanol, toluene or dimethylformamide.
所述的一种含噻唑环的仲胺类化合物的制备方法,其特征在于步骤1)中的微波加热反应的反应时间为10-30分钟,微波功率200-300W,反应温度90-150℃。The method for preparing a thiazole ring-containing secondary amine compound is characterized in that the reaction time of the microwave heating reaction in step 1) is 10-30 minutes, the microwave power is 200-300W, and the reaction temperature is 90-150°C.
所述的一种含噻唑环的仲胺类化合物的制备方法,其特征在于步骤2)中的(E)-N-(2-氯噻唑-5-yl)亚甲基胺衍生物与硼氢化钠的物质的量之比为1:0.75-2。The method for preparing a thiazole ring-containing secondary amine compound is characterized in that (E)-N-(2-chlorothiazole-5-yl)methyleneamine derivative and hydroboration in step 2) The ratio of the amount of sodium to the substance is 1:0.75-2.
所述的一种含噻唑环的仲胺类化合物的制备方法,其特征在于步骤2)中的有机溶剂B为甲醇、乙醇、四氢呋喃或二氯甲烷。The method for preparing a thiazole ring-containing secondary amine compound is characterized in that the organic solvent B in step 2) is methanol, ethanol, tetrahydrofuran or dichloromethane.
所述的一种含噻唑环的仲胺类化合物的制备方法,其特征在于步骤2)中的后处理过程如下:反应完毕旋蒸除去溶剂,用体积比为1:1的乙酸乙酯与水1:1混合溶剂萃取,分离有机相用无水硫酸钠干燥,过柱提纯得到产物。The method for preparing a thiazole ring-containing secondary amine compound is characterized in that the post-processing process in step 2) is as follows: after the reaction is completed, the solvent is removed by rotary evaporation, and ethyl acetate and water with a volume ratio of 1:1 are used. 1:1 mixed solvent extraction, the separated organic phase was dried with anhydrous sodium sulfate, and purified by column to obtain the product.
本发明的N-(2-氯噻唑-5-yl)甲基胺衍生物的反应过程如下:The reaction process of the N-(2-chlorothiazole-5-yl) methylamine derivative of the present invention is as follows:
通过采用上述技术,与现有技术相比,本发明取得如下有益效果:By adopting the above-mentioned technology, compared with the prior art, the present invention achieves the following beneficial effects:
本发明基于伯胺、2-氯-5-噻唑醛的结构,通过还原胺化的方式,先将醛、胺微波合成一系列仲胺化合物,然后用硼氢化钠将其还原为一系列仲胺化合物,最终设计合成了一系列N-(2-氯噻唑-5-yl)甲基胺化合物,其反应时间短,操作方便,转化率高,经济效益高,本发明所得的化合物可以用于制备介离子类杀虫剂。Based on the structure of primary amine and 2-chloro-5-thiazole aldehyde, the invention firstly microwaves aldehyde and amine to synthesize a series of secondary amine compounds by means of reductive amination, and then reduces them into a series of secondary amines with sodium borohydride The compound, finally designed and synthesized a series of N-(2-chlorothiazole-5-yl) methylamine compounds, the reaction time is short, the operation is convenient, the conversion rate is high, and the economic benefit is high, and the compounds obtained by the present invention can be used for preparation Ionic insecticides.
具体实施方式Detailed ways
下面结合具体实施例对本发明进行进一步描述,但本发明的保护范围并不仅限于此:The present invention is further described below in conjunction with specific embodiment, but the protection scope of the present invention is not limited to this:
实施例1 N-(2-氯噻唑-5-甲基)-3-甲基-2-吡啶胺的制备Example 1 Preparation of N-(2-chlorothiazole-5-methyl)-3-methyl-2-pyridinamine
将2-氯-5-噻唑醛(1.00g,6.76mmol)、3-甲基-2-吡啶胺(0.73g,6.76mmol)、无水乙酸钠(1.11g,13.54mmol)溶解在乙醇(15ml)中,滴加冰醋酸(0.5ml),置于微波反应釜并在90℃、300W的条件下反应15分钟,反应完毕过滤,气相色谱仪检测转化率为77.232%,脱溶得到(E)-N-(2-氯噻唑-5-亚甲基)-3-甲基-2-吡啶胺粗品,将(E)-N-(2-氯噻唑-5-亚甲基)-3-甲基-2-吡啶胺(1.50g,6.30mmol)、硼氢化钠(0.24g,6.32mmol)溶解在乙醇(15ml)中,常温搅拌大约3小时,TLC跟踪反应,反应完毕旋干溶剂,用乙酸乙酯(15ml)与水(15ml)混合萃取,分离有机相并用无水硫酸钠干燥,过滤,用纯石油醚过柱提纯,制得式(A1)所示的N-(2-氯噻唑-5-甲基)-3-甲基-2-吡啶胺。2-Chloro-5-thiazolaldehyde (1.00g, 6.76mmol), 3-methyl-2-pyridinamine (0.73g, 6.76mmol), anhydrous sodium acetate (1.11g, 13.54mmol) were dissolved in ethanol (15ml) ) in, drip glacial acetic acid (0.5ml), place microwave reactor and react 15 minutes under the condition of 90 ℃, 300W, the reaction finishes filtering, gas chromatograph detects conversion rate 77.232%, and precipitation obtains (E) -N-(2-chlorothiazole-5-methylene)-3-methyl-2-pyridinamine crude, (E)-N-(2-chlorothiazole-5-methylene)-3-methyl Base-2-pyridylamine (1.50g, 6.30mmol) and sodium borohydride (0.24g, 6.32mmol) were dissolved in ethanol (15ml), stirred at room temperature for about 3 hours, followed by TLC, after the reaction was completed, the solvent was spin-dried, and acetic acid was used. Ethyl ester (15ml) and water (15ml) were mixed and extracted, the organic phase was separated and dried with anhydrous sodium sulfate, filtered, and purified by column purification with pure petroleum ether to obtain N-(2-chlorothiazole- 5-Methyl)-3-methyl-2-pyridinamine.
N-(2-氯噻唑-5-甲基)-3-甲基-2-吡啶胺:白色固体,两步产率:65.3%;1H NMR(CDCl3,500MHz),δ:8.08(s,1H,thiazole),7.44(s,1H,pyridin),7.28-7.27(m,1H,pyridin),6.65-6.63(m,1H,pyridin),4.78(d,J=6.5Hz,2H,CH2),4.56(s,1H,NH),2.10(s,2H,CH3)。N-(2-Chlorothiazol-5-methyl)-3-methyl-2-pyridinamine: white solid, two-step yield: 65.3%; 1 H NMR (CDCl 3 , 500 MHz), δ: 8.08 (s , 1H, thiazole), 7.44(s, 1H, pyridin), 7.28-7.27(m, 1H, pyridin), 6.65-6.63(m, 1H, pyridin), 4.78(d, J=6.5Hz, 2H, CH 2 ), 4.56 (s, 1H, NH), 2.10 (s, 2H, CH3 ).
实施例2 N-(2-氯噻唑-5-yl)甲基苯胺的制备Example 2 Preparation of N-(2-chlorothiazole-5-yl) methylaniline
将2-氯-5-噻唑醛(1.00g,6.76mmol)、苯胺(0.63g,6.77mmol)、无水乙酸钠(1.11g,13.54mmol)溶解在乙醇(15ml)中,滴加冰醋酸(0.5ml),置于微波反应釜并在90℃、300W的条件下反应15分钟,反应完毕过滤,气相色谱仪检测转化率为95.232%,脱溶得到(E)-N-(2-氯噻唑-5-yl)亚甲基苯胺粗品,将(E)-N-(2-氯噻唑-5-yl)亚甲基苯胺(1.50g,6.73mmol)、硼氢化钠(0.25g,6.59mmol)溶解在乙醇(15ml)中,常温搅拌大约3小时,TLC跟踪反应,反应完毕旋干溶剂,用乙酸乙酯(15ml)与水(15ml)混合萃取,分离有机相并用无水硫酸钠干燥,过滤,用纯石油醚过柱提纯,制得式(A2)所示的N-(2-氯噻唑-5-yl)甲基苯胺。2-Chloro-5-thiazolaldehyde (1.00g, 6.76mmol), aniline (0.63g, 6.77mmol), anhydrous sodium acetate (1.11g, 13.54mmol) were dissolved in ethanol (15ml), and glacial acetic acid ( 0.5ml), placed in the microwave reactor and reacted for 15 minutes under the condition of 90 ° C, 300W, the reaction was completed and filtered, the gas chromatograph detected the conversion rate of 95.232%, and the precipitation obtained (E)-N-(2-chlorothiazole) -5-yl) methylene aniline crude product, (E)-N-(2-chlorothiazole-5-yl) methylene aniline (1.50 g, 6.73 mmol), sodium borohydride (0.25 g, 6.59 mmol) Dissolve in ethanol (15ml), stir at room temperature for about 3 hours, follow the reaction by TLC, spin dry the solvent after the reaction, mix and extract with ethyl acetate (15ml) and water (15ml), separate the organic phase and dry with anhydrous sodium sulfate, filter , purified by column with pure petroleum ether to obtain N-(2-chlorothiazole-5-yl)methylaniline represented by formula (A2).
N-(2-氯噻唑-5-yl)甲基苯胺:淡黄色油状,两步产率:85.3%;1H NMR(CDCl3,500MHz),δ:7.47(s,1H,thiazole),7.25-7.19(m,2H,ph),6.83-6.79(m,1H,ph),6.69-6.66(m,2H,ph),4.50(d,J=5.5Hz,2H,CH2),4.08(s,1H,NH)。N-(2-chlorothiazole-5-yl)methylaniline: pale yellow oil, two-step yield: 85.3%; 1 H NMR (CDCl 3 , 500MHz), δ: 7.47(s,1H,thiazole), 7.25 -7.19(m, 2H, ph), 6.83-6.79(m, 1H, ph), 6.69-6.66(m, 2H, ph), 4.50(d, J=5.5Hz, 2H, CH 2 ), 4.08(s ,1H,NH).
实施例3 N-((2-氯噻唑-5-yl)甲基)-3,4-二甲基苯胺的制备Example 3 Preparation of N-((2-chlorothiazole-5-yl)methyl)-3,4-dimethylaniline
将2-氯-5-噻唑醛(1.00g,6.76mmol)、3,4-二甲基苯胺(0.82g,6.78mmol)、无水乙酸钠(1.11g,13.54mmol)溶解在乙醇(15ml)中,滴加冰醋酸(0.5ml),置于微波反应釜并在90℃、300W的条件下反应15分钟,反应完毕过滤,气相色谱仪检测转化率为77.835%,脱溶得到(E)-N-((2-氯噻唑-5-yl)亚甲基)-3,4-二甲基苯胺粗品,将(E)-N-((2-氯噻唑-5-yl)亚甲基)-3,4-二甲基苯胺(1.50g,5.98mmol)、硼氢化钠(0.23g,6.05mmol)溶解在乙醇(15ml)中,常温搅拌大约3小时,TLC跟踪反应,反应完毕旋干溶剂,用乙酸乙酯(15ml)与水(15ml)混合萃取,分离有机相并用无水硫酸钠干燥,过滤,用纯石油醚过柱提纯,制得式(A3)所示的N-((2-氯噻唑-5-yl)甲基)-3,4-二甲基苯胺。2-Chloro-5-thiazolaldehyde (1.00 g, 6.76 mmol), 3,4-dimethylaniline (0.82 g, 6.78 mmol), and anhydrous sodium acetate (1.11 g, 13.54 mmol) were dissolved in ethanol (15 ml) In, add glacial acetic acid (0.5ml) dropwise, place microwave reactor and react 15 minutes under the condition of 90 ℃, 300W, after the reaction is completed, filter, gas chromatograph detects conversion rate 77.835%, and precipitation obtains (E)- Crude N-((2-chlorothiazole-5-yl)methylene)-3,4-dimethylaniline, (E)-N-((2-chlorothiazole-5-yl)methylene) -3,4-Dimethylaniline (1.50g, 5.98mmol) and sodium borohydride (0.23g, 6.05mmol) were dissolved in ethanol (15ml), stirred at room temperature for about 3 hours, followed by TLC, and the solvent was spin-dried after the reaction was completed , mixed with ethyl acetate (15ml) and water (15ml) for extraction, the organic phase was separated and dried with anhydrous sodium sulfate, filtered, and purified by column with pure petroleum ether to obtain N-((2) represented by formula (A3). -Chlorothiazol-5-yl)methyl)-3,4-dimethylaniline.
N-(2-氯噻唑-5-yl)-3,4-甲基苯胺:褐色油状,两步产率:73.1%。N-(2-Chlorothiazol-5-yl)-3,4-methylaniline: brown oil, two-step yield: 73.1%.
实施例4 N-((2-氯噻唑-5-yl)甲基)-4-乙基苯胺的制备Example 4 Preparation of N-((2-chlorothiazole-5-yl)methyl)-4-ethylaniline
将2-氯-5-噻唑醛(1.00g,6.76mmol)、4-乙基苯胺(0.82g,6.78mmol)、无水乙酸钠(1.11g,13.54mmol)溶解在乙醇(15ml)中,滴加冰醋酸(0.5ml),置于微波反应釜并在90℃、300W的条件下反应15分钟,反应完毕过滤,气相色谱仪检测转化率为72.281%,脱溶得到(E)-N-((2-氯噻唑-5-yl)亚甲基)-4-乙基苯胺粗品,将(E)-N-((2-氯噻唑-5-yl)亚甲基)-4-乙基苯胺(1.50g,5.98mmol)、硼氢化钠(0.23g,6.05mmol)溶解在乙醇(15ml)中,常温搅拌大约3小时,TLC跟踪反应,反应完毕旋干溶剂,用乙酸乙酯(15ml)与水(15ml)混合萃取,分离有机相并用无水硫酸钠干燥,过滤,用纯石油醚过柱提纯,制得式(A4)所示的N-((2-氯噻唑-5-yl)甲基)-4-乙基苯胺。2-Chloro-5-thiazolaldehyde (1.00g, 6.76mmol), 4-ethylaniline (0.82g, 6.78mmol), anhydrous sodium acetate (1.11g, 13.54mmol) were dissolved in ethanol (15ml), dropwise Add glacial acetic acid (0.5ml), place microwave reactor and react 15 minutes under the condition of 90 ℃, 300W, filter after completion of reaction, gas chromatograph detects transformation efficiency 72.281%, and precipitation obtains (E)-N-( (2-chlorothiazole-5-yl)methylene)-4-ethylaniline crude product, (E)-N-((2-chlorothiazole-5-yl)methylene)-4-ethylaniline (1.50g, 5.98mmol), sodium borohydride (0.23g, 6.05mmol) were dissolved in ethanol (15ml), stirred at room temperature for about 3 hours, TLC tracked the reaction, after the reaction was completed, the solvent was spin-dried and mixed with ethyl acetate (15ml). Water (15ml) was mixed and extracted, the organic phase was separated and dried with anhydrous sodium sulfate, filtered, and purified by column with pure petroleum ether to obtain N-((2-chlorothiazole-5-yl)methan represented by formula (A4). base)-4-ethylaniline.
N-(2-氯噻唑-5-yl)-4-乙基苯胺:褐色油状,两步产率:67.9%;1H NMR(CDCl3,500MHz),δ:7.46(s,1H,thiazole),7.06(d,J=8.5Hz,2H,ph),6.63-6.61(m,2H,ph),4.47(s,2H,CH2),3.94(s,1H,NH)。N-(2-chlorothiazole-5-yl)-4-ethylaniline: brown oil, two-step yield: 67.9%; 1 H NMR (CDCl 3 , 500 MHz), δ: 7.46 (s,1H,thiazole) , 7.06 (d, J=8.5 Hz, 2H, ph), 6.63-6.61 (m, 2H, ph), 4.47 (s, 2H, CH2 ), 3.94 (s, 1H, NH).
实施例5 N-((2-氯噻唑-5-yl)甲基)-2,6-二乙基苯胺的制备Example 5 Preparation of N-((2-chlorothiazole-5-yl)methyl)-2,6-diethylaniline
将2-氯-5-噻唑醛(1.00g,6.76mmol)、2,6-二乙基苯胺(1.01g,6.78mmol)、无水乙酸钠(1.11g,13.54mmol)溶解在乙醇(15ml)中,滴加冰醋酸(0.5ml),置于微波反应釜并在90℃、300W的条件下反应20分钟,反应完毕过滤,气相色谱仪检测转化率为89.265%,脱溶得到(E)-N-((2-氯噻唑-5-yl)亚甲基)-2,6-二乙基苯胺粗品,将(E)-N-((2-氯噻唑-5-yl)亚甲基)-2,6-二乙基苯胺(1.50g,5.38mmol)、硼氢化钠(0.20g,5.26mmol)溶解在乙醇(15ml)中,常温搅拌大约3小时,TLC跟踪反应,反应完毕旋干溶剂,用乙酸乙酯(15ml)与水(15ml)混合萃取,分离有机相并用无水硫酸钠干燥,过滤,用纯石油醚过柱提纯,制得式(A5)所示的N-((2-氯噻唑-5-yl)甲基)-2,6-二乙基苯胺。2-Chloro-5-thiazolaldehyde (1.00g, 6.76mmol), 2,6-diethylaniline (1.01g, 6.78mmol), anhydrous sodium acetate (1.11g, 13.54mmol) were dissolved in ethanol (15ml) In, add glacial acetic acid (0.5ml) dropwise, place microwave reactor and react 20 minutes under the condition of 90 ℃, 300W, after the reaction is completed, filter, gas chromatograph detects conversion rate 89.265%, and precipitation obtains (E)- Crude N-((2-chlorothiazole-5-yl)methylene)-2,6-diethylaniline, (E)-N-((2-chlorothiazole-5-yl)methylene) -2,6-Diethylaniline (1.50g, 5.38mmol) and sodium borohydride (0.20g, 5.26mmol) were dissolved in ethanol (15ml), stirred at room temperature for about 3 hours, followed by TLC, and the solvent was spin-dried after the reaction was completed , extracted by mixing ethyl acetate (15ml) and water (15ml), separating the organic phase and drying with anhydrous sodium sulfate, filtering, and purifying with pure petroleum ether through column to obtain N-((2) shown in formula (A5). -Chlorothiazol-5-yl)methyl)-2,6-diethylaniline.
N-(2-氯噻唑-5-yl)-2,6-二乙基苯胺:深红色油状,两步产率:85.5%。常规方法产率80.9%。N-(2-Chlorothiazol-5-yl)-2,6-diethylaniline: dark red oil, two-step yield: 85.5%. The yield of the conventional method was 80.9%.
实施例6 N-((2-氯噻唑-5-yl)甲基)-3-异丙基苯胺的制备Example 6 Preparation of N-((2-chlorothiazole-5-yl)methyl)-3-isopropylaniline
将2-氯-5-噻唑醛(1.00g,6.76mmol)、3-异丙基苯胺(0.91g,6.74mmol)、无水乙酸钠(1.11g,13.54mmol)溶解在乙醇(15ml)中,滴加冰醋酸(0.5ml),置于微波反应釜并在90℃、300W的条件下反应25分钟,反应完毕过滤,气相色谱仪检测转化率为93.060%,脱溶得到(E)-N-((2-氯噻唑-5-yl)亚甲基)-3-异丙基苯胺粗品,将(E)-N-((2-氯噻唑-5-yl)亚甲基)-3-异丙基苯胺(1.50g,5.66mmol)、硼氢化钠(0.21g,5.53mmol)溶解在乙醇(15ml)中,常温搅拌大约3小时,TLC跟踪反应,反应完毕旋干溶剂,用乙酸乙酯(15ml)与水(15ml)混合萃取,分离有机相并用无水硫酸钠干燥,过滤,用纯石油醚过柱提纯,制得式(A6)所示的N-((2-氯噻唑-5-yl)甲基)-3-异丙基苯胺。2-Chloro-5-thiazolaldehyde (1.00g, 6.76mmol), 3-isopropylaniline (0.91g, 6.74mmol), anhydrous sodium acetate (1.11g, 13.54mmol) were dissolved in ethanol (15ml), Glacial acetic acid (0.5ml) was added dropwise, placed in a microwave reactor and reacted for 25 minutes under the conditions of 90° C. and 300W, the reaction was completed and filtered, the gas chromatograph detected the conversion rate as 93.060%, and the precipitation obtained (E)-N- ((2-chlorothiazole-5-yl)methylene)-3-isopropylaniline crude product, (E)-N-((2-chlorothiazole-5-yl)methylene)-3-isopropylaniline Propylaniline (1.50g, 5.66mmol) and sodium borohydride (0.21g, 5.53mmol) were dissolved in ethanol (15ml), stirred at room temperature for about 3 hours, followed by TLC, the reaction was completed and the solvent was spin-dried, and ethyl acetate ( 15ml) mixed with water (15ml) and extracted, the organic phase was separated and dried with anhydrous sodium sulfate, filtered, and purified by column with pure petroleum ether to obtain N-((2-chlorothiazole-5-) represented by formula (A6). yl) methyl)-3-isopropylaniline.
N-(2-氯噻唑-5-yl)-3-异丙基苯胺:深红色油状,两步产率:88.7%;1H NMR(CDCl3,500MHz),δ:7.47(s,1H,thiazole),7.16-7.13(m,1H,ph),6.70(d,J=7.5Hz,1H,ph),6.59(s,1H,ph),6.51-6.49(m,1H,ph),4.49(d,J=5.5Hz,2H,CH2),4.04(s,1H,NH),2.87-2.81(m,1H,CH),1.30-1.24(m,6H,CH3)。N-(2-Chlorothiazol-5-yl)-3-isopropylaniline: dark red oil, two-step yield: 88.7%; 1 H NMR (CDCl 3 , 500 MHz), δ: 7.47 (s, 1H, thiazole), 7.16-7.13(m, 1H, ph), 6.70(d, J=7.5Hz, 1H, ph), 6.59(s, 1H, ph), 6.51-6.49(m, 1H, ph), 4.49( d, J=5.5Hz, 2H, CH2 ), 4.04 (s, 1H, NH), 2.87-2.81 (m, 1H, CH), 1.30-1.24 (m, 6H, CH3 ).
实施例7 N-((2-氯噻唑-5-yl)甲基)-2-甲氧基苯胺的制备Example 7 Preparation of N-((2-chlorothiazole-5-yl)methyl)-2-methoxyaniline
将2-氯-5-噻唑醛(1.00g,6.76mmol)、2-甲氧基苯胺(0.83g,6.75mmol)、无水乙酸钠(1.11g,13.54mmol)溶解在乙醇(15ml)中,滴加冰醋酸(0.5ml),置于微波反应釜并在90℃、300W的条件下反应25分钟,反应完毕过滤,气相色谱仪检测转化率为94.811%,脱溶得到(E)-N-((2-氯噻唑-5-yl)亚甲基)-2-甲氧基苯胺粗品,将(E)-N-((2-氯噻唑-5-yl)亚甲基)-2-甲氧基苯胺(1.50g,5.93mmol)、硼氢化钠(0.23g,6.05mmol)溶解在乙醇(15ml)中,常温搅拌大约3小时,TLC跟踪反应,反应完毕旋干溶剂,用乙酸乙酯(15ml)与水(15ml)混合萃取,分离有机相并用无水硫酸钠干燥,过滤,用纯石油醚过柱提纯,制得式(A7)所示的N-((2-氯噻唑-5-yl)甲基)-2-甲氧基苯胺。2-Chloro-5-thiazolaldehyde (1.00 g, 6.76 mmol), 2-methoxyaniline (0.83 g, 6.75 mmol), and anhydrous sodium acetate (1.11 g, 13.54 mmol) were dissolved in ethanol (15 ml), Glacial acetic acid (0.5ml) was added dropwise, placed in a microwave reactor and reacted for 25 minutes under the conditions of 90° C. and 300W, the reaction was completed and filtered, the gas chromatograph detected the conversion rate as 94.811%, and the precipitation obtained (E)-N- ((2-chlorothiazole-5-yl)methylene)-2-methoxyaniline crude product, (E)-N-((2-chlorothiazole-5-yl)methylene)-2-methyl Oxyaniline (1.50g, 5.93mmol) and sodium borohydride (0.23g, 6.05mmol) were dissolved in ethanol (15ml), stirred at room temperature for about 3 hours, followed by TLC, the reaction was completed and the solvent was spin-dried, and ethyl acetate ( 15ml) was mixed with water (15ml) and extracted, the organic phase was separated and dried with anhydrous sodium sulfate, filtered, and purified by column with pure petroleum ether to obtain N-((2-chlorothiazole-5-) represented by formula (A7). yl) methyl)-2-methoxyaniline.
N-(2-氯噻唑-5-yl)-2-甲氧基苯胺:褐色油状,两步产率:90.1%。N-(2-Chlorothiazol-5-yl)-2-methoxyaniline: brown oil, two-step yield: 90.1%.
实施例8 N-((2-氯噻唑-5-yl)甲基)-2,5-二甲氧基苯胺的制备Example 8 Preparation of N-((2-chlorothiazole-5-yl)methyl)-2,5-dimethoxyaniline
将2-氯-5-噻唑醛(1.00g,6.76mmol)、2,5-二甲氧基苯胺(1.03g,6.73mmol)、无水乙酸钠(1.11g,13.54mmol)溶解在乙醇(15ml)中,滴加冰醋酸(0.5ml),置于微波反应釜并在90℃、300W的条件下反应25分钟,反应完毕过滤,气相色谱仪检测转化率为81.096%,脱溶得到(E)-N-((2-氯噻唑-5-yl)亚甲基)-2,5-二甲氧基苯胺粗品,将(E)-N-((2-氯噻唑-5-yl)亚甲基)-2,5-二甲氧基苯胺(1.50g,5.30mmol)、硼氢化钠(0.20g,5.26mmol)溶解在乙醇(15ml)中,常温搅拌大约3小时,TLC跟踪反应,反应完毕旋干溶剂,用乙酸乙酯(15ml)与水(15ml)混合萃取,分离有机相并用无水硫酸钠干燥,过滤,用纯石油醚过柱提纯,制得式(A8)所示的N-((2-氯噻唑-5-yl)甲基)-2,5-二甲氧基苯胺。2-Chloro-5-thiazolaldehyde (1.00g, 6.76mmol), 2,5-dimethoxyaniline (1.03g, 6.73mmol), anhydrous sodium acetate (1.11g, 13.54mmol) were dissolved in ethanol (15ml) ) in, drip glacial acetic acid (0.5ml), place microwave reactor and react 25 minutes under the condition of 90 ℃, 300W, the reaction finishes filtering, gas chromatograph detects conversion rate 81.096%, and precipitation obtains (E) -N-((2-chlorothiazole-5-yl)methylene)-2,5-dimethoxyaniline crude product, (E)-N-((2-chlorothiazole-5-yl)methylene Base)-2,5-dimethoxyaniline (1.50g, 5.30mmol), sodium borohydride (0.20g, 5.26mmol) were dissolved in ethanol (15ml), stirred at room temperature for about 3 hours, TLC tracked the reaction, the reaction was completed Spin dry the solvent, mix and extract with ethyl acetate (15ml) and water (15ml), separate the organic phase and dry with anhydrous sodium sulfate, filter, and purify with pure petroleum ether to obtain the N- ((2-Chlorothiazol-5-yl)methyl)-2,5-dimethoxyaniline.
N-(2-氯噻唑-5-yl)-2,5-二甲氧基苯胺:黑色油状,两步产率:77.4%。N-(2-Chlorothiazol-5-yl)-2,5-dimethoxyaniline: black oil, two-step yield: 77.4%.
实施例9 N-((2-氯噻唑-5-yl)甲基)-3-氟苯胺的制备Example 9 Preparation of N-((2-chlorothiazole-5-yl)methyl)-3-fluoroaniline
将2-氯-5-噻唑醛(1.00g,6.76mmol)、3-氟苯胺(0.75g,6.76mmol)、无水乙酸钠(1.11g,13.54mmol)溶解在乙醇(15ml)中,滴加冰醋酸(0.5ml),置于微波反应釜并在90℃、300W的条件下反应30分钟,反应完毕过滤,气相色谱仪检测转化率为89.625%,脱溶得到(E)-N-((2-氯噻唑-5-yl)亚甲基)-3-氟苯胺粗品,将(E)-N-((2-氯噻唑-5-yl)亚甲基)-3-氟苯胺(1.50g,6.22mmol)、硼氢化钠(0.24g,6.32mmol)溶解在乙醇(15ml)中,常温搅拌大约3小时,TLC跟踪反应,反应完毕旋干溶剂,用乙酸乙酯(15ml)与水(15ml)混合萃取,分离有机相并用无水硫酸钠干燥,过滤,用纯石油醚过柱提纯,制得式(A9)所示的N-((2-氯噻唑-5-yl)甲基)-3-氟苯胺。2-Chloro-5-thiazolaldehyde (1.00 g, 6.76 mmol), 3-fluoroaniline (0.75 g, 6.76 mmol), and anhydrous sodium acetate (1.11 g, 13.54 mmol) were dissolved in ethanol (15 ml), and added dropwise Glacial acetic acid (0.5ml) was placed in the microwave reactor and reacted for 30 minutes under the condition of 90 ° C, 300W, the reaction was completed and filtered, the gas chromatograph detected the conversion rate of 89.625%, and the precipitation obtained (E)-N-(( 2-chlorothiazole-5-yl)methylene)-3-fluoroaniline crude product, (E)-N-((2-chlorothiazole-5-yl)methylene)-3-fluoroaniline (1.50g) , 6.22mmol), sodium borohydride (0.24g, 6.32mmol) were dissolved in ethanol (15ml), stirred at room temperature for about 3 hours, TLC tracked the reaction, the reaction was completed by spin-drying the solvent, with ethyl acetate (15ml) and water (15ml) ) mixed extraction, the organic phase was separated and dried with anhydrous sodium sulfate, filtered, and purified by column with pure petroleum ether to obtain N-((2-chlorothiazole-5-yl)methyl)- 3-Fluoroaniline.
N-(2-氯噻唑-5-yl)-3-氟苯胺:深红色油状,两步产率:85.4%;1H NMR(CDCl3,500MHz),δ:7.48(s,1H,thiazole),7.16-7.09(m,1H,ph),6.51-6.34(m,3H,ph),4.47(d,J=5.5Hz,2H,CH2),4.22(s,1H,NH)。N-(2-chlorothiazole-5-yl)-3-fluoroaniline: dark red oil, two-step yield: 85.4%; 1 H NMR (CDCl 3 , 500MHz), δ: 7.48(s,1H,thiazole) , 7.16-7.09 (m, 1H, ph), 6.51-6.34 (m, 3H, ph), 4.47 (d, J=5.5Hz, 2H, CH2 ), 4.22 (s, 1H, NH).
实施例10 N-((2-氯噻唑-5-yl)甲基)-3,4-二氟苯胺的制备Example 10 Preparation of N-((2-chlorothiazole-5-yl)methyl)-3,4-difluoroaniline
将2-氯-5-噻唑醛(1.00g,6.76mmol)、3,4-二氟苯胺(0.87g,6.74mmol)、无水乙酸钠(1.11g,13.54mmol)溶解在乙醇(15ml)中,滴加冰醋酸(0.5ml),置于微波反应釜并在90℃、300W的条件下反应30分钟,反应完毕过滤,气相色谱仪检测转化率为78.945%,脱溶得到(E)-N-((2-氯噻唑-5-yl)亚甲基)-3,4-二氟苯胺粗品,将(E)-N-((2-氯噻唑-5-yl)亚甲基)-3,4-二氟苯胺(1.50g,5.79mmol)、硼氢化钠(0.22g,5.79mmol)溶解在乙醇(15ml)中,常温搅拌大约3小时,TLC跟踪反应,反应完毕旋干溶剂,用乙酸乙酯(15ml)与水(15ml)混合萃取,分离有机相并用无水硫酸钠干燥,过滤,用纯石油醚过柱提纯,制得式(A11)所示的N-((2-氯噻唑-5-yl)甲基)-3,4-二氟苯胺。2-Chloro-5-thiazolaldehyde (1.00 g, 6.76 mmol), 3,4-difluoroaniline (0.87 g, 6.74 mmol), anhydrous sodium acetate (1.11 g, 13.54 mmol) were dissolved in ethanol (15 ml) , glacial acetic acid (0.5ml) was added dropwise, placed in a microwave reactor and reacted for 30 minutes under the condition of 90 ° C, 300W, the reaction was completed and filtered, the gas chromatograph detected the conversion rate of 78.945%, and the precipitation obtained (E)-N -((2-chlorothiazole-5-yl)methylene)-3,4-difluoroaniline crude product, (E)-N-((2-chlorothiazole-5-yl)methylene)-3 , 4-Difluoroaniline (1.50g, 5.79mmol), sodium borohydride (0.22g, 5.79mmol) were dissolved in ethanol (15ml), stirred at room temperature for about 3 hours, TLC followed the reaction, after the reaction was completed, the solvent was spin-dried, and acetic acid was used. Ethyl ester (15ml) and water (15ml) were mixed and extracted, the organic phase was separated and dried with anhydrous sodium sulfate, filtered, and purified by column with pure petroleum ether to obtain N-((2-chlorothiazole) represented by formula (A11). -5-yl)methyl)-3,4-difluoroaniline.
N-(2-氯噻唑-5-yl)-3,4-二氟苯胺:深红色油状,两步产率:74.2%。N-(2-Chlorothiazol-5-yl)-3,4-difluoroaniline: dark red oil, two-step yield: 74.2%.
实施例11 N-((2-氯噻唑-5-yl)甲基)-2-三氟甲基苯胺的制备Example 11 Preparation of N-((2-chlorothiazole-5-yl)methyl)-2-trifluoromethylaniline
将2-氯-5-噻唑醛(1.00g,6.76mmol)、2-三氟甲基苯胺(1.09g,6.77mmol)、无水乙酸钠(1.11g,13.54mmol)溶解在乙醇(15ml)中,滴加冰醋酸(0.5ml),置于微波反应釜并在90℃、300W的条件下反应20分钟,反应完毕过滤,气相色谱仪检测转化率为73.864%,脱溶得到(E)-N-((2-氯噻唑-5-yl)亚甲基)-2-三氟甲基苯胺粗品,将(E)-N-((2-氯噻唑-5-yl)亚甲基)-2-三氟甲基苯胺(1.50g,5.15mmol)、硼氢化钠(0.20g,5.26mmol)溶解在乙醇(15ml)中,常温搅拌大约3小时,TLC跟踪反应,反应完毕旋干溶剂,用乙酸乙酯(15ml)与水(15ml)混合萃取,分离有机相并用无水硫酸钠干燥,过滤,用纯石油醚过柱提纯,制得式(A11)所示的N-((2-氯噻唑-5-yl)甲基)-2-三氟甲基苯胺。2-Chloro-5-thiazolaldehyde (1.00 g, 6.76 mmol), 2-trifluoromethylaniline (1.09 g, 6.77 mmol), anhydrous sodium acetate (1.11 g, 13.54 mmol) were dissolved in ethanol (15 ml) , glacial acetic acid (0.5ml) was added dropwise, placed in a microwave reactor and reacted for 20 minutes under the condition of 90° C., 300W, the reaction was completed and filtered, the gas chromatograph detected the conversion rate of 73.864%, and the precipitation obtained (E)-N -((2-chlorothiazole-5-yl)methylene)-2-trifluoromethylaniline crude product, (E)-N-((2-chlorothiazole-5-yl)methylene)-2 -Trifluoromethylaniline (1.50g, 5.15mmol), sodium borohydride (0.20g, 5.26mmol) were dissolved in ethanol (15ml), stirred at room temperature for about 3 hours, TLC followed the reaction, after the reaction was completed, the solvent was spin-dried, and acetic acid was used. Ethyl ester (15ml) and water (15ml) were mixed and extracted, the organic phase was separated and dried with anhydrous sodium sulfate, filtered, and purified by column with pure petroleum ether to obtain N-((2-chlorothiazole) represented by formula (A11). -5-yl)methyl)-2-trifluoromethylaniline.
N-(2-氯噻唑-5-yl)-2-三氟甲基苯胺:深红色油状,两步产率:70.1%。N-(2-Chlorothiazol-5-yl)-2-trifluoromethylaniline: dark red oil, two-step yield: 70.1%.
实施例12 N-((2-氯噻唑-5-yl)甲基)-4-三氟甲基苯胺的制备Example 12 Preparation of N-((2-chlorothiazole-5-yl)methyl)-4-trifluoromethylaniline
将2-氯-5-噻唑醛(1.00g,6.76mmol)、4-三氟甲基苯胺(1.09g,6.77mmol)、无水乙酸钠(1.11g,13.54mmol)溶解在乙醇(15ml)中,滴加冰醋酸(0.5ml),置于微波反应釜并在90℃、300W的条件下反应25分钟,反应完毕过滤,气相色谱仪检测转化率为99.494%,脱溶得到(E)-N-((2-氯噻唑-5-yl)亚甲基)-4-三氟甲基苯胺粗品,将(E)-N-((2-氯噻唑-5-yl)亚甲基)-4-三氟甲基苯胺(1.50g,5.15mmol)、硼氢化钠(0.20g,5.26mmol)溶解在乙醇(15ml)中,常温搅拌大约3小时,TLC跟踪反应,反应完毕旋干溶剂,用乙酸乙酯(15ml)与水(15ml)混合萃取,分离有机相并用无水硫酸钠干燥,过滤,用纯石油醚过柱提纯,制得式(A12)所示的N-((2-氯噻唑-5-yl)甲基)-4-三氟甲基苯胺。2-Chloro-5-thiazolaldehyde (1.00 g, 6.76 mmol), 4-trifluoromethylaniline (1.09 g, 6.77 mmol), anhydrous sodium acetate (1.11 g, 13.54 mmol) were dissolved in ethanol (15 ml) , glacial acetic acid (0.5ml) was added dropwise, placed in a microwave reactor and reacted for 25 minutes under the conditions of 90° C., 300W, the reaction was completed and filtered, the gas chromatograph detected the conversion rate of 99.494%, and the precipitation obtained (E)-N -((2-chlorothiazole-5-yl)methylene)-4-trifluoromethylaniline crude product, (E)-N-((2-chlorothiazole-5-yl)methylene)-4 -Trifluoromethylaniline (1.50g, 5.15mmol), sodium borohydride (0.20g, 5.26mmol) were dissolved in ethanol (15ml), stirred at room temperature for about 3 hours, TLC followed the reaction, after the reaction was completed, the solvent was spin-dried, and acetic acid was used. Ethyl ester (15ml) and water (15ml) were mixed and extracted, the organic phase was separated and dried with anhydrous sodium sulfate, filtered, and purified by column with pure petroleum ether to obtain N-((2-chlorothiazole) represented by formula (A12) -5-yl)methyl)-4-trifluoromethylaniline.
N-(2-氯噻唑-5-yl)-4-三氟甲基苯胺:褐色油状,两步产率:90.2%。N-(2-Chlorothiazol-5-yl)-4-trifluoromethylaniline: brown oil, two-step yield: 90.2%.
实施例13 N-((2-氯噻唑-5-yl)甲基)-2-三氟甲氧基苯胺的制备Example 13 Preparation of N-((2-chlorothiazole-5-yl)methyl)-2-trifluoromethoxyaniline
将2-氯-5-噻唑醛(1.00g,6.76mmol)、2-三氟甲氧基苯胺(1.19g,6.72mmol)、无水乙酸钠(1.11g,13.54mmol)溶解在乙醇(15ml)中,滴加冰醋酸(0.5ml),置于微波反应釜并在90℃、300W的条件下反应20分钟,反应完毕过滤,气相色谱仪检测转化率为84.715%,脱溶得到(E)-N-((2-氯噻唑-5-yl)亚甲基)-2-三氟甲氧基苯胺粗品,将(E)-N-((2-氯噻唑-5-yl)亚甲基)-2-三氟甲氧基苯胺(1.50g,4.89mmol)、硼氢化钠(0.19g,5.00mmol)溶解在乙醇(15ml)中,常温搅拌大约3小时,TLC跟踪反应,反应完毕旋干溶剂,用乙酸乙酯(15ml)与水(15ml)混合萃取,分离有机相并用无水硫酸钠干燥,过滤,用纯石油醚过柱提纯,制得式(A13)所示的N-((2-氯噻唑-5-yl)甲基)-2-三氟甲氧基苯胺。2-Chloro-5-thiazolaldehyde (1.00 g, 6.76 mmol), 2-trifluoromethoxyaniline (1.19 g, 6.72 mmol), anhydrous sodium acetate (1.11 g, 13.54 mmol) were dissolved in ethanol (15 ml) In, add glacial acetic acid (0.5ml) dropwise, place microwave reactor and react 20 minutes under the condition of 90 ℃, 300W, the reaction finishes filtering, gas chromatograph detects conversion rate 84.715%, precipitation obtains (E)- Crude N-((2-chlorothiazole-5-yl)methylene)-2-trifluoromethoxyaniline, (E)-N-((2-chlorothiazole-5-yl)methylene) -2-Trifluoromethoxyaniline (1.50g, 4.89mmol) and sodium borohydride (0.19g, 5.00mmol) were dissolved in ethanol (15ml), stirred at room temperature for about 3 hours, followed by TLC, and the solvent was spin-dried after the reaction was completed , mixed with ethyl acetate (15ml) and water (15ml) for extraction, the organic phase was separated and dried with anhydrous sodium sulfate, filtered, and purified by column with pure petroleum ether to obtain N-((2) represented by formula (A13). -Chlorothiazol-5-yl)methyl)-2-trifluoromethoxyaniline.
N-(2-氯噻唑-5-yl)-2-三氟甲氧基苯胺:黄色油状,两步产率:80.3%。N-(2-Chlorothiazol-5-yl)-2-trifluoromethoxyaniline: yellow oil, two-step yield: 80.3%.
实施例14 3-氯-N-((2-氯噻唑-5-yl)甲基)苯胺的制备Example 14 Preparation of 3-chloro-N-((2-chlorothiazole-5-yl)methyl)aniline
将2-氯-5-噻唑醛(1.00g,6.76mmol)、3-氯苯胺(0.86g,6.72mmol)、无水乙酸钠(1.11g,13.54mmol)溶解在乙醇(15ml)中,滴加冰醋酸(0.5ml),置于微波反应釜并在90℃、300W的条件下反应15分钟,反应完毕过滤,气相色谱仪检测转化率为71.290%,脱溶得到(E)-3-氯-N-((2-氯噻唑-5-yl)亚甲基)苯胺粗品,将(E)-3-氯-N-((2-氯噻唑-5-yl)亚甲基)苯胺(1.50g,5.81mmol)、硼氢化钠(0.22g,5.79mmol)溶解在乙醇(15ml)中,常温搅拌大约3小时,TLC跟踪反应,反应完毕旋干溶剂,用乙酸乙酯(15ml)与水(15ml)混合萃取,分离有机相并用无水硫酸钠干燥,过滤,用纯石油醚过柱提纯,制得式(A14)所示的3-氯-N-((2-氯噻唑-5-yl)甲基)苯胺。2-Chloro-5-thiazolaldehyde (1.00 g, 6.76 mmol), 3-chloroaniline (0.86 g, 6.72 mmol), and anhydrous sodium acetate (1.11 g, 13.54 mmol) were dissolved in ethanol (15 ml), and added dropwise Glacial acetic acid (0.5ml) was placed in a microwave reactor and reacted for 15 minutes under the condition of 90°C and 300W, the reaction was completed and filtered, and the gas chromatograph detected the conversion rate as 71.290%, and the precipitation obtained (E)-3-chloro- Crude N-((2-chlorothiazole-5-yl)methylene)aniline, (E)-3-chloro-N-((2-chlorothiazole-5-yl)methylene)aniline (1.50 g) , 5.81mmol), sodium borohydride (0.22g, 5.79mmol) were dissolved in ethanol (15ml), stirred at room temperature for about 3 hours, TLC tracked the reaction, the reaction was completed and the solvent was spin-dried, and ethyl acetate (15ml) and water (15ml) were used. ) mixed extraction, the organic phase was separated and dried with anhydrous sodium sulfate, filtered, and purified by column with pure petroleum ether to obtain 3-chloro-N-((2-chlorothiazole-5-yl) represented by formula (A14) methyl)aniline.
3-氯-N-(2-氯噻唑-5-yl)-3,4-甲基苯胺:黄色油状,两步产率:68.1%;1H NMR(CDCl3,500MHz),δ:7.47(s,1H,thiazole),7.13-7.09(m,1H,ph),6.77-6.76(m,1H,ph),6.66(s,1H,ph),6.54-6.52(m,1H,ph),4.45(d,J=5.5Hz,2H,CH2),4.14(s,1H,NH)。3-Chloro-N-(2-chlorothiazole-5-yl)-3,4-methylaniline: yellow oil, two-step yield: 68.1%; 1 H NMR (CDCl 3 , 500 MHz), δ: 7.47 ( s,1H,thiazole),7.13-7.09(m,1H,ph),6.77-6.76(m,1H,ph),6.66(s,1H,ph),6.54-6.52(m,1H,ph),4.45 (d, J=5.5Hz, 2H, CH2 ), 4.14 (s, 1H, NH).
实施例15 4-氯-N-((2-氯噻唑-5-yl)甲基)苯胺的制备Example 15 Preparation of 4-chloro-N-((2-chlorothiazole-5-yl)methyl)aniline
将2-氯-5-噻唑醛(1.00g,6.76mmol)、4-氯苯胺(0.86g,6.72mmol)、无水乙酸钠(1.11g,13.54mmol)溶解在乙醇(15ml)中,滴加冰醋酸(0.5ml),置于微波反应釜并在90℃、300W的条件下反应15分钟,反应完毕过滤,气相色谱仪检测转化率为72.354%,脱溶得到(E)-4-氯-N-((2-氯噻唑-5-yl)亚甲基)苯胺粗品,将(E)-4-氯-N-((2-氯噻唑-5-yl)亚甲基)苯胺(1.50g,5.81mmol)、硼氢化钠(0.22g,5.79mmol)溶解在乙醇(15ml)中,常温搅拌大约3小时,TLC跟踪反应,反应完毕旋干溶剂,用乙酸乙酯(15ml)与水(15ml)混合萃取,分离有机相并用无水硫酸钠干燥,过滤,用纯石油醚过柱提纯,制得式(A15)所示的4-氯-N-((2-氯噻唑-5-yl)甲基)苯胺。2-Chloro-5-thiazolaldehyde (1.00 g, 6.76 mmol), 4-chloroaniline (0.86 g, 6.72 mmol), and anhydrous sodium acetate (1.11 g, 13.54 mmol) were dissolved in ethanol (15 ml), and added dropwise Glacial acetic acid (0.5ml) was placed in a microwave reactor and reacted for 15 minutes under the condition of 90° C. and 300W, the reaction was completed and filtered, and the gas chromatograph detected that the conversion rate was 72.354%, and the precipitation obtained (E)-4-chloro- Crude N-((2-chlorothiazole-5-yl)methylene)aniline, (E)-4-chloro-N-((2-chlorothiazole-5-yl)methylene)aniline (1.50 g) , 5.81mmol), sodium borohydride (0.22g, 5.79mmol) were dissolved in ethanol (15ml), stirred at room temperature for about 3 hours, TLC tracked the reaction, the reaction was completed and the solvent was spin-dried, and ethyl acetate (15ml) and water (15ml) were used. ) mixed extraction, separated the organic phase and dried with anhydrous sodium sulfate, filtered, and purified by column with pure petroleum ether to obtain 4-chloro-N-((2-chlorothiazole-5-yl) represented by formula (A15) methyl)aniline.
4-氯-N-(2-氯噻唑-5-yl)-3,4-甲基苯胺:黄色油状,两步产率:67.7%;1H NMR(CDCl3,500MHz),δ:7.45(s,1H,thiazole),7.17-7.14(m,2H,ph),6.60-6.57(m,2H,ph),4.47(d,J=5Hz,2H,CH2),4.12(s,1H,NH)。4-Chloro-N-(2-chlorothiazole-5-yl)-3,4-methylaniline: yellow oil, two-step yield: 67.7%; 1 H NMR (CDCl 3 , 500 MHz), δ: 7.45 ( s, 1H, thiazole), 7.17-7.14 (m, 2H, ph), 6.60-6.57 (m, 2H, ph), 4.47 (d, J=5Hz, 2H, CH 2 ), 4.12 (s, 1H, NH ).
本发明所得的化合物可以用于制备介离子类杀虫剂。The compounds obtained in the present invention can be used to prepare mesoionic insecticides.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010878159.9A CN111978314A (en) | 2020-08-27 | 2020-08-27 | A kind of preparation method of secondary amine compound containing thiazole ring |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010878159.9A CN111978314A (en) | 2020-08-27 | 2020-08-27 | A kind of preparation method of secondary amine compound containing thiazole ring |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111978314A true CN111978314A (en) | 2020-11-24 |
Family
ID=73439990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010878159.9A Pending CN111978314A (en) | 2020-08-27 | 2020-08-27 | A kind of preparation method of secondary amine compound containing thiazole ring |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111978314A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008061795A2 (en) * | 2006-11-24 | 2008-05-29 | Ac Immune Sa | N- (methyl) -1h- pyrazol- 3 -amine, n- (methyl) -pyridin-2-amine and n- (methyl) -thiaz0l-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. alzheimer's |
TW201734002A (en) * | 2015-12-11 | 2017-10-01 | 拜耳作物科學股份有限公司 | Substituted malonamides as insecticides |
-
2020
- 2020-08-27 CN CN202010878159.9A patent/CN111978314A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008061795A2 (en) * | 2006-11-24 | 2008-05-29 | Ac Immune Sa | N- (methyl) -1h- pyrazol- 3 -amine, n- (methyl) -pyridin-2-amine and n- (methyl) -thiaz0l-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. alzheimer's |
TW201734002A (en) * | 2015-12-11 | 2017-10-01 | 拜耳作物科學股份有限公司 | Substituted malonamides as insecticides |
Non-Patent Citations (2)
Title |
---|
NUGZAR GHAVTADZE ET AL.: "Indole as Neutral Leaving Group in Silver Nitrate Induced Cyclization Reactions of N-{2-[Alkynyl(hetero)aryl]methylene}indolin-1-amines for the Synthesis of Annulated Pyridine Derivatives", 《EUR. J. ORG. CHEM.》 * |
刘鹰翔: "《药物合成反应》", 31 August 2017, 中国中医药出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1043349A (en) | Therapeutic 1-hydroxyaryl-2-amidoalkylaminoethanol derivatives | |
CN111943944B (en) | Ethylthio-containing pyridine-bis-1, 2, 4-oxadiazole substituted benzamide compound and preparation method and application thereof | |
CH616917A5 (en) | ||
CN107129499A (en) | Fused heterocycle compounds of imidazole ring-containing and its preparation method and application | |
CN102153488B (en) | A kind of α, β-diamino acid derivative and its synthesis method and application | |
CA2859992A1 (en) | Novel morpholinyl derivatives useful as mogat-2 inhibitors | |
CN108003086B (en) | A kind of preparation method of 3-amino-2-indolone compounds | |
CN105524013B (en) | 4,5- bis- substitutes the preparation method of -2- substituted-amino thiazolium compounds | |
CN111978314A (en) | A kind of preparation method of secondary amine compound containing thiazole ring | |
CN102531995B (en) | 3,3'-disubstituted-3-hydroxy bis-indolinone derivative and preparation method and application thereof | |
CN106336395A (en) | Benzamide derivatives containing urea bridge and preparation method and application thereof | |
CN107200731B (en) | A kind of thiazole ring-containing pyridone derivative and its preparation method and application | |
CN110038632B (en) | Preparation of a sulfonic acid functionalized lignin heterogeneous catalyst and a method for synthesizing amide compounds using the catalyst | |
Finkelstein et al. | Synthesis of cis-and trans-2-phenoxycyclopropylamines and related compounds | |
CN110041237B (en) | Synthetic method of alpha-amino acid derivative | |
CN102971301B (en) | anti-tuberculosis drugs | |
CA2531787A1 (en) | Sulfonamide derivatives as 5ht7 receptor antagonists | |
CN106243109B (en) | A kind of 1,2,4- triazole derivatives of the structure of benzopyrazines containing methyl and its preparation method and application | |
CN106467536B (en) | The method that the luxuriant zirconium Lewis acid efficient catalytics of orthanilic acid collaboration prepare Azabicyclic compounds | |
CN102503882B (en) | Halogenated benzaldehyde indole Schiff base as well as preparation method and application thereof | |
DE2320058A1 (en) | NEW PROPYLENE DIAMINE DERIVATIVES AND METHOD FOR MANUFACTURING THE SAME | |
CN106831785A (en) | A kind of Aminopyrrolizineton compound and its synthetic method | |
CN106957298B (en) | A kind of lipoic acid phenol ester derivative and preparation method and application thereof | |
CN104387440A (en) | Betulin amino-acid ester compound, and preparation method and application thereof | |
CN105254530A (en) | Method for synthesizing Schiff base compound containing camphenyl |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201124 |